TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
TransMedics's operating income for the twelve months ending Jun 30, 2026 was $81.61M, up 6.6% year over year. For fiscal 2025 it was $108.58M, up 189.6% from the year before. The highest annual figure on record is $108.58M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.58M | +189.6% |
| FY2024 | Dec 31, 2024 | $37.50M | – |
| FY2023 | Dec 31, 2023 | -$28.73M | – |
| FY2022 | Dec 31, 2022 | -$31.44M | – |
| FY2021 | Dec 31, 2021 | -$39.43M | – |
| FY2020 | Dec 31, 2020 | -$26.38M | – |
| FY2019 | Dec 28, 2019 | -$29.60M | – |
| FY2018 | Dec 29, 2018 | -$20.24M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.74M | -35.1% |
| Q1 FY2026 | Mar 31, 2026 | $13.30M | -51.5% |
| Q4 FY2025 | Dec 31, 2025 | $21.27M | +146.1% |
| Q3 FY2025 | Sep 30, 2025 | $23.30M | +493.9% |
| Q2 FY2025 | Jun 30, 2025 | $36.57M | +192.3% |
| Q1 FY2025 | Mar 31, 2025 | $27.44M | +120.9% |
| Q4 FY2024 | Dec 31, 2024 | $8.64M | +232.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.92M | – |
| Q2 FY2024 | Jun 30, 2024 | $12.51M | – |
| Q1 FY2024 | Mar 31, 2024 | $12.42M | – |
| Q4 FY2023 | Dec 31, 2023 | $2.60M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$906.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.78M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.54M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.75M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.37M | – |
| Q4 FY2021 | Dec 31, 2021 | -$11.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.87M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.51M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.61M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.86M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.02M | – |
| Q4 FY2019 | Dec 28, 2019 | -$8.69M | – |
| Q3 FY2019 | Sep 28, 2019 | -$7.24M | – |
| Q2 FY2019 | Jun 29, 2019 | -$7.71M | – |
| Q1 FY2019 | Mar 30, 2019 | -$5.96M | – |
| Q4 FY2018 | Dec 29, 2018 | -$6.36M | – |
| Q3 FY2018 | Sep 29, 2018 | -$3.94M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.16M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.78M | – |
See a number that looks wrong?